Godavari Drugs Ltd - Stock Valuation and Financial Performance

BSE: 530317 | NSE: | Pharmaceuticals & Drugs | Small Cap

Godavari Drugs Share Price

92.90 0.70 0.76%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Godavari Drugs

M-Cap below 100cr DeciZen not available

Godavari Drugs stock performance -

mw4me loader
P/E Ratio (SA):
16.46
Market Cap:
69.4 Cr.
52-wk low:
73.3
52-wk high:
114

Is Godavari Drugs Ltd an attractive stock to invest in?

1. Is Godavari Drugs Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Godavari Drugs Ltd is a below average quality company.

2. Is Godavari Drugs Ltd undervalued or overvalued?

The key valuation ratios of Godavari Drugs Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Godavari Drugs Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Godavari Drugs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Godavari Drugs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Godavari Drugs Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 15.2%23.4%10.1%9.9%6.8%8.4%9.1%12.3%13.8%12.5%-
Value Creation
Index
0.10.7-0.3-0.3-0.5-0.4-0.4-0.10.0-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 9.454.971.175.664.583.595.7123161160155
Sales YoY Gr.-481.7%29.7%6.3%-14.8%29.6%14.6%28.2%31.3%-0.9%-
Adj EPS 2.14.61.71.70.81.62.65.37.26.55.6
YoY Gr.-122.3%-63.1%2.4%-53.2%91.4%68.4%103.5%35.2%-9.6%-
BVPS (₹) 12.617.319.121.522.624.226.932.439.444.448.2
Adj Net
Profit
1.63.51.31.30.61.2245.44.94
Cash Flow from Ops. 2.2-5.9-4.55.23.83.76.21.311.213.2-
Debt/CF from Ops. 1.1-1.5-3.43.155.94.422.92.12.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 36.9%19.9%18.6%-0.9%
Adj EPS 13.6%51.6%35.5%-9.6%
BVPS15%14.4%18.2%12.8%
Share Price 25.1% 33% 27.4% 17.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
17.830.69.38.53.76.610.217.92015.512.1
Op. Profit
Mgn %
19.510.66.476.36.66.387.27.47.4
Net Profit
Mgn %
16.56.31.81.711.42.13.33.43.12.7
Debt to
Equity
0.30.71.111.11.21.41.30.81.1-
Working Cap
Days
26098154180249221219188157179103
Cash Conv.
Cycle
10943586078727570505614

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 18.59%

Net Profit is growing at healthy rate in last 3 years 35.48%

Return on Equity has declined versus last 3 years average to 12.10%

Debt to equity has increased versus last 3 years average to 1.07

Sales growth is not so good in last 4 quarters at -6.19%

Latest Financials - Godavari Drugs Ltd.

Standalone Consolidated
TTM EPS (₹) 5.6 -
TTM Sales (₹ Cr.) 155 -
BVPS (₹.) 48.2 -
Reserves (₹ Cr.) 29 -
P/BV 1.91 -
PE 16.46 -
From the Market
52 Week Low / High (₹) 73.31 / 114.00
All Time Low / High (₹) 1.00 / 114.00
Market Cap (₹ Cr.) 69.4
Equity (₹ Cr.) 7.5
Face Value (₹) 10
Industry PE 47.8

Management X-Ray of Godavari Drugs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *14.515.185.165.115.111.250.121.251.251.25
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Godavari Drugs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales9.4354.8571.1275.6064.4583.5495.70122.67161.11159.62
Operating Expenses 7.5949.0666.6370.3760.3978.0689.66112.83149.82149.70
Manufacturing Costs3.345.063.946.675.386.016.108.179.8910.22
Material Costs1.1440.4158.6858.9449.2764.9176.6796.59130.46128.06
Employee Cost 1.462.012.172.382.673.453.453.944.964.84
Other Costs 1.641.581.842.373.063.683.444.134.516.59
Operating Profit 1.845.784.505.234.065.496.049.8411.299.92
Operating Profit Margin (%) 19.5%10.5%6.3%6.9%6.3%6.6%6.3%8.0%7.0%6.2%
Other Income 0.120.300.190.800.680.240.330.410.280.66
Interest 0.210.671.882.522.442.902.913.322.853.93
Depreciation 1.050.680.630.810.991.091.161.221.701.94
Exceptional Items 0000000000.23
Profit Before Tax 0.704.732.182.711.311.752.295.717.024.93
Tax -0.851.090.830.900.480.540.291.581.781.15
Profit After Tax 1.553.651.351.810.831.2124.135.253.79
PAT Margin (%) 16.4%6.6%1.9%2.4%1.3%1.4%2.1%3.4%3.3%2.4%
Adjusted EPS (₹)2.14.81.82.41.11.62.75.57.05.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 9.5113.0614.4116.2217.0518.2620.2624.3929.6333.42
Share Capital 7.537.537.537.537.537.537.537.537.537.53
Reserves 1.985.536.888.699.5210.7312.7316.8622.1025.89
Minority Interest0000000000
Debt2.428.4815.4815.7218.1421.0126.0828.0820.3433.50
Long Term Debt2.423.643.924.396.608.0111.1614.4911.7811.95
Short Term Debt04.8411.5611.3311.541314.9113.598.5621.55
Trade Payables0.568.7817.3620.0623.0230.3630.2729.5043.3246.15
Others Liabilities 2.374.423.303.704.824.107.319.178.128.37
Total Liabilities 14.8634.7450.5455.7063.0273.7483.9291.14101.41121.43

Fixed Assets

Gross Block24.8823.1125.0829.9332.7034.2034.2144.0549.5746.28
Accumulated Depreciation16.6715.8316.3517.1618.1519.2320.4021.6223.3221.37
Net Fixed Assets8.217.288.7312.7714.5614.9713.8122.4326.2524.91
CWIP 00.421.200.120.972.058.930.760.499.08
Investments 0000000000
Inventories3.049.2810.7411.3213.4716.4717.7514.6510.0319.86
Trade Receivables0.5113.1324.5524.1726.7833.9636.0245.1255.5857.94
Cash Equivalents 0.250.260.650.881.621.531.431.642.283.08
Others Assets2.854.384.686.445.644.775.986.546.786.57
Total Assets 14.8634.7450.5455.7063.0273.7483.9291.14101.41121.43

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 2.24-5.85-4.535.153.823.716.241.3311.2313.22
PBT 1.553.651.352.711.315.722.295.697.024.93
Adjustment 0.662.420.562.512.73-0.243.754.134.275.22
Changes in Working Capital -0.21-11.5-5.660.430.35-1.490.6-6.921.724.22
Tax Paid 000-0.50-0.57-0.28-0.39-1.58-1.78-1.15
Cash Flow From Investing Activity -2.29-0.20-2.08-2.97-2.95-2.34-6.68-1.25-4.97-8.64
Capex -2.29-0.20-2.08-3.77-3.62-2.58-6.89-1.67-5.25-9.15
Net Investments 0000000000
Others 0000.800.680.240.210.420.270.51
Cash Flow From Financing Activity 0.026.076.99-1.95-0.14-1.460.340.13-5.62-3.77
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0.681.230.150.472.211.413.153.33-2.710.17
Interest Paid 000-2.51-2.42-2.89-2.91-3.31-2.85-3.93
Dividend Paid 0000000000
Others -0.664.846.850.090.060.010.100.12-0.06-0.01
Net Cash Flow -0.020.010.390.230.73-0.09-0.100.210.640.81
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)17.7732.329.8411.814.996.8510.3918.4919.4212.01
ROCE (%)8.1832.315.7716.8911.0112.1411.817.5818.3514.53
Asset Turnover Ratio0.632.481.861.561.091.221.211.41.671.43
PAT to CFO Conversion(x)1.45-1.6-3.362.854.63.073.120.322.143.49
Working Capital Days
Receivable Days234087107144133133121114130
Inventory Days119374649706565482834
Payable Days1854281116160150144113102128

Godavari Drugs Ltd Stock News

Godavari Drugs Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Godavari Drugs on 28-Mar-2024 16:01 is ₹92.90.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Godavari Drugs stood at ₹69.43.
The latest P/E ratio of Godavari Drugs as of 28-Mar-2024 16:01 is 16.46.
The latest P/B ratio of Godavari Drugs as of 28-Mar-2024 16:01 is 1.91.
The 52-week high of Godavari Drugs is ₹114.0 and the 52-week low is ₹73.31.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Godavari Drugs is ₹155.4 ( Cr.) .

About Godavari Drugs Ltd

Godavari Drugs was incorporated as a private limited company on December 2, 1987 and subsequently converted into a public limited company on September 25, 1992.  It was promoted by Ghanshyam Jaju, Mukund Kakani and PC Shrimal. 

The company has set up a project to manufacture 180 TPA at Sulphamethoxazole (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class ‘C’ backward district in Maharashtra. The project was fully commissioned on July 3, 1989.

The registered office of the company is located at Secunderabad in Andhra Pradesh and Mukund Kakani is its Managing Director.

Business area of the company

The company’s principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.